http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8165514

Outgoing Links

Predicate Object
contentType Journal Article
issn 2234-943X
pageRange 1398-
publicationName Frontiers in Oncology
startingPage 1398
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation Zhou HH, Chen X, Cai LY, Nan XW, Chen JH, Chen XX, Yang Y, Xing ZH, Wei MN, Li Y, Wang ST, Liu K, Shi Z, Yan XJ. Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer. Front Oncol. 2019;9():1398. PMID: 31921655; PMCID: PMC6930896.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64023215088b625d3dbd14a935f58796
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f34bc74bade86aac6828bce2bb68c2d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e084c73945cc16818dbb6b25924793b4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20371442c972add6a5899b6df5a464e2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33262a798e62fb5a55672d217fc4f20a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2f443d46ca271701ca4afe5f684f7fd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db1a6c89769cd7bacc0c226a3e633b6b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f20900a0941890d15e0de33bfef1d570
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_859ff7dea7755fdbf7c06614f207f862
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf743ded47ce9165d38df06357f2ca01
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4eb37453f788bceaae3d1cce2cae15b4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11aeda329ac97354d56b3a9e13df292b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25a081f897d38d3d4a6d031a2a9ce7e2
date 2019-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/31921655
https://pubmed.ncbi.nlm.nih.gov/31850227
https://doi.org/10.3389/fonc.2019.01345
https://doi.org/10.3389/fonc.2019.01398
https://pubmed.ncbi.nlm.nih.gov/PMC6930896
isPartOf https://portal.issn.org/resource/ISSN/2234-943X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39509
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2b41adbd094947475b63355088c8b2f4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5909ca9e3ba0327220498d6e9cfab117
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_efdbbf9d9f20cdf89f19d5cc9171b33b
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11214940

Total number of triples: 40.